Fears of AI Disruption Rattle Investors
WSJ Minute Briefing
The Wall Street Journal
4.1 • 671 Ratings
🗓️ 4 February 2026
⏱️ 3 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | I think the potential of Agenic is to rethink how work gets done overall. |
| 0:05.0 | It challenges all sorts of traditional orthodoxies around how organizations execute the work at hand. |
| 0:11.3 | That's Jason Gersatus, CEO of Deloitte U.S., talking about the transformational potential of A.Gentic AI. |
| 0:17.9 | Join him later to learn why agents are a game changer for businesses across industries. |
| 0:25.3 | Here's your morning brief for Wednesday, February 4th. I'm Daniel Bach for the Wall Street Journal. |
| 0:30.5 | Software stocks in Asia and Europe are sliding today following a rough day on Wall Street |
| 0:34.6 | that saw the rise of new AI tools shave more than $300 billion |
| 0:38.7 | off of companies that sell or invest in software. Yesterday's big losers include Adobe, |
| 0:44.7 | Salesforce, PayPal, Expedia, Equifax, and LegalZoom.com, as traders called into question the |
| 0:50.4 | competitive advantages of the software they license. Hyper-scalers behind leading AI products, including Magnificent 7 companies, aren't immune from that, though. |
| 1:00.0 | Microsoft dipped almost 3% yesterday on concerns AI tools could make enterprise subscriptions to the company's co-pilot assistant less necessary. |
| 1:08.9 | According to City Research, some companies are using just 10% of the |
| 1:12.5 | co-pilot subscription seats they've paid for. Shares of drug maker Novo Nordisk are plunging this |
| 1:18.3 | morning after the maker of weight loss drugs, OZempec and Wagovi cut its sales forecast and warned |
| 1:23.3 | up unprecedented pricing pressure. Novo is facing intense competition from Eli Lilly in the GLP1 drug market, after both companies |
| 1:31.7 | agreed to reduce the prices of their drugs in some markets in exchange for some coverage |
| 1:36.4 | with the Trump administration. |
| 1:38.2 | Eli Lilly, the maker of Zepbound, is set to report earnings later this morning. |
| 1:42.9 | And President Trump has doubled down on his view that |
| 1:45.0 | Republicans should nationalize voting in the U.S. Flanked by congressional Republicans in the Oval Office, |
| 1:51.2 | Trump hit out at battleground states as places of alleged corruption without citing specific evidence |
| 1:56.6 | and question whether they should continue to run their own elections as the Constitution spells out. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.